Back to Search
Start Over
After Ailing, Booster Shot For Biotech.
- Source :
-
Wall Street Journal - Eastern Edition . 12/30/2015, Vol. 266 Issue 153, pC1-C2. 2p. 1 Graph. - Publication Year :
- 2015
-
Abstract
- The article states that the stock index the Nasdaq Biotechnology Index enjoyed an increase of 18 percent from its September 2015 low to the end of 2015, spurred by an increase in the price of stock in biotechnology firms such as Celgene Corp., Gilead Sciences, Inc., and Biogen Inc. The article presents comments from investment firm Oak Ridge Investments chief investment officer David Klaskin.
- Subjects :
- *FINANCING of biotechnology industries
*STOCK prices
Subjects
Details
- Language :
- English
- ISSN :
- 00999660
- Volume :
- 266
- Issue :
- 153
- Database :
- Academic Search Index
- Journal :
- Wall Street Journal - Eastern Edition
- Publication Type :
- News
- Accession number :
- 111997440